Novartis US Foundation COVID-19 Response

In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one-year period for immediate response and recovery efforts related to the pandemic. • Funding will support local initiatives and communities in the US impacted by the outbreak.  Initial grants will focus on immediate need for digital tools and frontline medical organization needs, including: $250,000 grant to the Commons Project for the development of COVIDcheck, a free public digital health service under development with global, national, state and local public health authorities; $125,000 grants to Americares and Direct Relief to support US safety net clinics.

Content from this campaign

Philanthropy
Novartis and the Novartis US Foundation Establish USD 5 Million US COVID-19 Community Response Fund
Novartis announced today, that in response to the COVID-19 pandemic in the US, Novartis and the Novartis US Foundation have established a US COVID-19 Community Response Fund.

More from Novartis

The Novartis Malaria Initiative

For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...